Incyte Corp. (INCY)
111.36
-1.42
(-1.26%)
USD |
NASDAQ |
Oct 12, 16:00
108.40
-2.96
(-2.66%)
After-Hours: 17:17
Incyte Price : 111.36 for Oct. 12, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 09, 2026 | 112.35 | 113.87 | 111.80 | 112.79 | 1.122M |
| Oct 08, 2026 | 112.89 | 113.75 | 110.08 | 112.75 | 1.927M |
| Oct 07, 2026 | 112.82 | 115.49 | 112.46 | 113.44 | 1.275M |
| Oct 06, 2026 | 114.13 | 114.97 | 111.67 | 112.73 | 2.460M |
| Oct 05, 2026 | 115.14 | 115.67 | 112.83 | 114.13 | 1.949M |
| Oct 02, 2026 | 116.76 | 117.19 | 114.57 | 115.30 | 2.170M |
| Oct 01, 2026 | 120.47 | 121.22 | 117.00 | 117.14 | 2.365M |
| Sep 30, 2026 | 123.00 | 124.23 | 121.03 | 121.35 | 1.620M |
| Sep 29, 2026 | 123.67 | 125.47 | 121.89 | 123.20 | 1.719M |
| Sep 28, 2026 | 123.32 | 126.14 | 122.53 | 124.82 | 1.436M |
| Sep 25, 2026 | 125.72 | 126.00 | 123.07 | 123.89 | 1.210M |
| Sep 24, 2026 | 124.79 | 125.55 | 123.03 | 124.44 | 1.405M |
| Sep 23, 2026 | 127.51 | 128.21 | 123.89 | 124.64 | 1.534M |
| Sep 22, 2026 | 124.72 | 127.75 | 124.01 | 126.93 | 1.647M |
| Sep 21, 2026 | 125.00 | 127.41 | 124.19 | 124.65 | 1.271M |
| Sep 18, 2026 | 127.85 | 128.72 | 125.23 | 125.31 | 3.700M |
| Sep 17, 2026 | 125.74 | 127.74 | 125.10 | 127.62 | 1.469M |
| Sep 16, 2026 | 121.48 | 124.96 | 121.48 | 124.75 | 1.347M |
| Sep 15, 2026 | 121.58 | 122.19 | 119.97 | 121.74 | 1.564M |
| Sep 14, 2026 | 122.48 | 123.34 | 121.28 | 122.19 | 1.456M |
| Sep 11, 2026 | 124.35 | 124.35 | 121.42 | 121.47 | 1.425M |
| Sep 10, 2026 | 125.09 | 126.31 | 122.58 | 123.28 | 1.463M |
| Sep 09, 2026 | 125.66 | 127.72 | 123.57 | 126.01 | 1.301M |
| Sep 08, 2026 | 124.10 | 126.40 | 122.22 | 124.40 | 1.283M |
| Sep 04, 2026 | 126.46 | 128.08 | 126.04 | 126.75 | 1.036M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Regeneron Pharmaceuticals, Inc. | 763.24 |
| Mirum Pharmaceuticals, Inc. | 86.08 |
| Alnylam Pharmaceuticals, Inc. | 227.05 |
| Vertex Pharmaceuticals, Inc. | 506.98 |
| AbbVie, Inc. | 281.04 |
Price Related Metrics
| PE Ratio | 14.19 |
| PS Ratio | 3.929 |
| PEG Ratio | 0.1811 |
| Price to Book Value | 3.528 |
| Price to Free Cash Flow | 12.09 |
| Earnings Yield | 7.05% |
| Market Cap | 22.38B |
| PEGY Ratio | 0.1811 |
| Operating PE Ratio | 12.43 |
| Normalized PE Ratio | 13.97 |